Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Remote ECG Monitoring-Based Phase I Cardiac Rehabilitation After Heart Surgery

NCT: NCT07736066 · COMPLETED

NCT IDNCT07736066
StatusCOMPLETED
Start Date2021-08-01
Completion2023-08-31
SponsorHUINNO Co., Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

This prospective, single-arm study aims to evaluate the effectiveness of Phase I cardiac rehabilitation based on remote electrocardiographic (ECG) monitoring in patients undergoing heart surgery. Eligible participants will receive a comprehensive cardiac rehabilitation program consisting of inpatient and home-based rehabilitation while wearing the MEMO Patch for remote ECG monitoring. Clinical outcomes, including functional exercise capacity, exercise performance, muscle strength, physical function, and health-related quality of life, will be evaluated before rehabilitation, before hospital discharge, and after completion of the rehabilitation program.

Frequently Asked Questions

What is Remote ECG Monitoring-Based Phase I Cardiac Rehabilitation After Heart Surgery?

Remote ECG Monitoring-Based Phase I Cardiac Rehabilitation After Heart Surgery is a clinical trial registered under NCT07736066. Current status: COMPLETED.

What is the status of NCT07736066?

The current status of NCT07736066 (Remote ECG Monitoring-Based Phase I Cardiac Rehabilitation After Heart Surgery) is: COMPLETED.

When did Remote ECG Monitoring-Based Phase I Cardiac Rehabilitation After Heart Surgery start?

Remote ECG Monitoring-Based Phase I Cardiac Rehabilitation After Heart Surgery started on 2021-08-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.